Unlicensed Cosmetic Injections and Federal Exposure: What a Houston Lip Filler Case Means for Florida Med Spas

A dental assistant in Houston is now facing criminal charges over lip filler injections she allegedly performed without medical licensing. The case is being prosecuted under Texas law, but the fact pattern is the one that turns a state licensing problem into a federal investigation. If you operate a med spa, employ injectors, or supervise a clinic in Florida, the lesson here is not about Texas. It is about how fast an unlicensed-injector allegation can pull in the FDA, federal fraud statutes, and a grand jury.

A Houston dental assistant was charged after allegedly performing lip filler injections without medical licensing. The same fact pattern — unlicensed provider, unregulated product, patient harm — is the front end of a federal investigation.

Key Takeaways

A Houston dental assistant was charged after allegedly injecting lip filler without medical licensing, with prosecutors citing a patient infection and the state medical practice statute. The same conduct can trigger federal exposure under 21 U.S.C. § 331 and § 333 when the injectable is a misbranded or unapproved drug or device. Where billing touches Medicare or private insurers, 18 U.S.C. § 1347 (health care fraud) and § 1349 (conspiracy) put exposure at up to 10 years per count. Florida treats unlicensed practice of medicine as a felony under Fla. Stat. § 458.327, and South Florida is one of the most active federal med spa enforcement zones in the country. These cases are won pre-indictment. By the time a target letter or grand jury subpoena arrives, the defense window is already closing.

What Actually Happened

According to ABC13 Houston, a dental assistant was charged after prosecutors alleged she performed lip filler injections without the medical licensing those procedures require. The business operated out of a salon suite. Prosecutors alleged that a client developed an infection after a February injection and later contacted police.

State records reportedly showed the injector held a dental assistant credential, not a license authorizing cosmetic injections. The reporting also noted an active social media presence advertising cosmetic procedures. The defendant was released on bond, and the judge barred her from the spa while the case proceeds.

The original reporting names the individual. We do not, because the point here is the pattern, not the person. The pattern is what every Florida med spa owner needs to understand.

""

Why a State Licensing Charge is the Front End of a Federal Case

Unlicensed-injector cases rarely stay small. Once investigators look past the licensing question, they ask three more. Where did the product come from? Was it an FDA-approved drug or device, or research-grade or imported material? And did anyone bill insurance or a federal health care program for it?

Texas regulators classify nonsurgical cosmetic injections as delegated medical acts under Texas Administrative Code § 169.25, which requires physician delegation, training, and emergency availability. Florida draws the same line. When the answer to any of those follow-up questions points to misbranded product or fraudulent billing, the matter stops being a board complaint and becomes a federal investigation.

The FDA Office of Criminal Investigations and federal prosecutors have been aggressive on injectables sourced outside the legitimate supply chain. A clinic that thinks it has a state scope-of-practice problem can find itself the subject of a federal drug-and-fraud investigation built from its own purchase records.

Exposure and Charges

The federal statutes that attach to these fact patterns carry real time.

21 U.S.C. § 331 and § 333: introducing or receiving a misbranded or unapproved drug or device. Dermal fillers are regulated as devices and neuromodulators as drugs. Felony exposure when done with intent to defraud or mislead.

18 U.S.C. § 1347 (health care fraud): up to 10 years per count, and up to 20 if serious bodily injury results.

18 U.S.C. § 1349 (conspiracy) and § 1341 / § 1343 (mail and wire fraud): the workhorses for advertising and payment conduct.

42 U.S.C. § 1320a-7b (Anti-Kickback Statute): exposure where referral or supervision arrangements involve federal program patients.

Loss amount drives the guideline range under USSG § 2B1.1. In a med spa case, "loss" can include the full billed amount across every patient, not just the one who complained. That is how a single infection complaint becomes a multi-count federal indictment with a guideline range measured in years.

When the FDA Office of Criminal Investigations enters a clinic, investigators are looking past the licensing question to the product source and the billing record.

Critical Mistakes People Make Early

Talking to investigators or board personnel without counsel, on the theory that cooperation will make it go away. It rarely does, and the statements get used.

Handing over patient files, purchase invoices, and supervision agreements without a strategy or a privilege review.

Assuming that because no charges have been filed, the matter is not serious. Pre-indictment is exactly when federal prosecutors are deciding whether to charge.

Scrubbing social media or deleting records after learning of an investigation. That converts a regulatory problem into an obstruction charge.

Strategic Defense Approach

The work that matters happens before an indictment. Early defense counsel can map the actual exposure, lock down the supply-chain and supervision records, and open a controlled dialogue with the prosecutor before the government commits to a charging theory.

For a clinic owner or supervising physician, the early questions are concrete. Who actually performed the procedures? Was there a valid delegation and good-faith examination? Where did the product come from, and is there documentation? Was anything billed to insurance? The answers determine whether this is a licensing defense, a federal fraud defense, or both.

""

Why Timing Matters

Charging decisions are fluid early. Once a grand jury returns an indictment, leverage shifts hard to the government. The window to influence whether a case is charged at all, and on what theory, is open only briefly. In a med spa matter, that window often opens the day a patient files a complaint or a board opens an inquiry, long before anyone uses the word "federal." Acting in that window is the single biggest variable in the outcome.

Common Questions

Can a state unlicensed-practice charge really turn into a federal case?

Yes. Federal investigators look past the licensing question to the product and the billing. If the injectable was a misbranded or unapproved drug or device, 21 U.S.C. §§ 331 and 333 apply. If anyone billed Medicare or insurers, 18 U.S.C. § 1347 applies. The same conduct supports parallel state and federal charges.

Should I talk to investigators if they come to my med spa?

Not without counsel. You are not required to give a statement, and anything you say can anchor a later charge. Be polite, decline to be interviewed on the spot, and call a federal criminal defense attorney before producing any document or answering substantive questions.

Why does Florida see so many federal med spa investigations?

South Florida is one of the most active federal health care enforcement zones in the country, with dedicated FDA, HHS-OIG, and U.S. Attorney resources. Florida also treats unlicensed practice of medicine as a felony under Fla. Stat. § 458.327, which gives state and federal authorities parallel paths.

No one has charged me yet. Do I still need a lawyer?

That is the most important time to have one. Pre-indictment is when prosecutors decide whether and what to charge. Early counsel can shape the supply-chain and supervision record, manage document production, and engage the prosecutor before a charging theory locks in.

Facing a Med Spa Licensing or Federal Investigation in Florida?

AMC Defense Law represents med spa owners, physicians, APRNs, PAs, and injectors in licensing matters and federal investigations involving misbranded drugs, health care fraud, and cosmetic injectables, in Florida and nationwide. If you have received a board complaint, a target letter, or a grand jury subpoena, or you simply want to understand your exposure, contact the firm for a confidential consultation.

Pre-indictment defense gives AMC Defense Law the window to map exposure, review supply-chain and supervision records, and engage the prosecutor before a charging theory locks in.

If you operate a med spa or supervise injectors in Florida and are facing a board inquiry or federal investigation, call Aaron M. Cohen for a confidential consultation.

Aaron M. Cohen is the founder of AMC Defense Law, a federal and state criminal defense firm based in Florida. The firm represents clients in federal investigations and prosecutions involving health care fraud, white-collar crime, peptide and compounded-drug enforcement, financial crimes, and complex federal litigation, in Florida and nationwide.

This article is for general informational purposes only and does not constitute legal advice, does not create an attorney-client relationship, and should not be relied upon in place of consultation with qualified counsel.